The past decade has seen major advances in the biomedical field, specifically in stem-cell research, regenerative medicine and transplantation. In response, cell therapy and gene therapy products are evolving at a corresponding pace. Nitta Gelatin's beMatrix™ low endotoxin gelatin and collagen are specifically designed to meet the most stringent safety and quality specifications required for emerging biomedical applications. In addition to setting the industry gold-standard for low endotoxin levels, beMatrix™ Gelatin and Collagen are also sterilized using a proprietary method for the control of bacteria and viruses.
New techniques to combine cells with low endotoxin gelatin or collagen are leading the way in biomedical research and development. Recently, beMatrix™ Collagen AT was chosen as the material for a retinal pigment epithelial sheet in the first human clinical study based on iPS cells. In the field of regenerative medicine, beMatrix™ Gelatin was successfully used as the scaffolding material for the in-growth of new bone for osteoconductive implants.